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Our aim was to provide a descriptive overview of how the birth defects surveillance and folic acid 
fortification programs were implemented in Costa Rica—through the establishment of the 
Registry Center for Congenital Anomalies (Centro de Registro de Enfermedades Congénitas—
CREC), and fortification legislation mandates. We estimated the overall prevalence of neural tube 
defects (i.e., spina bifida, anencephaly and encephalocele) before and after fortification captured 
by CREC. Prevalence was calculated by dividing the total number of infants born with neural tube 
defects by the total number of live births in the country (1987–2012).A total of 1,170 newborns 
with neural tube defects were identified from 1987 to 2012 (1992–1995 data excluded); 628 were 
identified during the baseline pre-fortification period (1987–1991; 1996–1998); 191 during the 
fortification period (1999–2002); and 351 during the post-fortification time period (2003–2012). 
The overall prevalence of neural tube defects decreased from 9.8 per 10,000 live-births (95 % CI 
9.1–10.5) for the pre-fortification period to 4.8 per 10,000 live births (95 % CI 4.3–5.3) for the 
post–fortification period. Results indicate a statistically significant (P < 0.05) decrease of 51 % in 
the prevalence of neural tube defects from the pre-fortification period to the post-fortification 
period. Folic acid fortification via several basic food sources has shown to be a successful public 
health intervention for Costa Rica. Costa Rica’s experience can serve as an example for other 
countries seeking to develop and strengthen both their birth defects surveillance and fortification 
programs.
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Introduction
Approximately 300,000 neural tube defects occur each year worldwide [1]. Neural tube 
defects, such as spina bifida, anencephaly, and encephalocele, are severe birth defects that 
affect the development of the spine and brain [2, 3]. These defects occur due to the failure of 
the neural tube to close properly, which usually happens between the 3rd and 4th weeks of 
gestation [4]. Studies showed that the consumption of folic acid before pregnancy and 
during early stages of gestation, through vitamin supplements containing folic acid or folic 
acid alone, can greatly reduce a woman’s risk for having a pregnancy affected by a neural 
tube defect [5–7].
Costa Rica, a country in Central America bordered by Nicaragua and Panama, is home to an 
estimated 4.6 million people [8]. In Costa Rica, 99 % of births occur in public and private 
hospitals (clinics) [9]. In 2010, the World Health Organization estimated that, 37 % of 
deaths in children aged <5 years in Costa Rica are due to birth defects, making them the 
leading cause of death in this age group [10]. In 2011, there were 73,459 births, and infant 
mortality was estimated to be 91 deaths per 10,000 live births [8]. The infant mortality rate 
associated with neural tube defects in Costa Rica in 2009 was 1.7 per 10,000 live births [11]. 
Costa Rica has shown that targeted neural tube defects prevention efforts, such as food 
fortification, have led to a significant decrease in the overall prevalence of neural tube 
defects [11, 12] and the prevalence of infant mortality due to neural tube defects [11].
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This manuscript describes how both the birth defect surveillance system and folic acid 
fortification programs in Costa Rica originated and developed. In 1985, the Registry Center 
for Congenital Anomalies (Centro de Registro de Enfermedades Congénitas—CREC) began 
monitoring birth defects in Costa Rica. In 1997, the first executive decree mandated the 
enrichment of wheat flour with folic acid. The role of folic acid fortification in the decline of 
neural tube defects prevalence in Costa Rica is well captured by CREC.
History of the Birth Defects Surveillance System in Costa Rica
In 1984, a birth defects research project was undertaken to understand the prevalence of 
birth defects and the neonatal mortality associated with birth defects in Costa Rica. The 
project received political support from officials and evolved into a mandatory surveillance 
system. In August 1985, executive decree 16488-S was established in Costa Rica [13]. This 
decree instituted mandatory reporting of all infants born with birth defects, detected at birth 
in all hospitals in the country. The mandate also led to the formation of the CREC, which 
serves as the central registry to which data are reported from all Costa Rican hospitals. In the 
early stages of the CREC, a coordinating group was formed, which included geneticists from 
the Costa Rica Institute of Research and Education for Nutrition and Health (Instituto 
Costarricense de Investigación y Enseñanza en Nutrición y Salud—INCIENSA), a branch of 
the Costa Rican Ministry of Health, along with a group of neonatologists from the public 
maternity hospitals from the Costa Rican Social Security System (Caja Costarricense del 
Seguro Social) and other collaborators. This coordinating group was charged with 
developing case definitions and designing the birth defects data collection instruments and 
the program’s protocol for surveillance [14]. In the beginning, CREC’s case definition for 
newborns with a birth defect includes both live births and stillbirths (terminations of 
pregnancy are not legal in Costa Rica, therefore are not part of the inclusion criteria), with a 
gestational weight of 500 g or more, born to resident and nonresident mothers, and born with 
any birth defect identified up to 7 days after delivery. The system has passive reporting of 
cases (i.e., hospital staff who identify babies born with birth defects report pertinent 
information directly to the surveillance program) [14, 15]. CREC verifies completeness of 
reported cases by reviewing all forms received at CREC, and by calling participating 
hospitals for any missing data. Coding and analysis of data are done at CREC and birth 
prevalence results are shared with all stakeholders of the surveillance system. In 1987, the 
protocol developed by CREC began fully operating in all maternity hospitals (n = 24) from 
the Costa Rican Social Security System. Although the surveillance system had a great deal 
of support from clinicians and hospital staff, in the early stages it was difficult for CREC 
staff to monitor reports from all hospitals, in particular those in more remote areas and those 
with fewer number of births. In 1991, some hospitals were having difficulty reporting, and 
CREC realized that the system was not ascertaining all newborns with birth defects. CREC 
decided to use their limited resources more strategically. In 1992, a decision was made to 
include only eight hospitals from the Costa Rican Social Security System to continue to 
participate in the surveillance program. These hospitals were chosen because of their large 
numbers of births (covering approximately 53 % of total births), and their ability to report 
complete data. Starting in 1996, CREC re-instituted reporting from all maternity hospitals in 
the country—both public (n = 24) and private (n = 4)—to move towards providing more 
accurate population data.
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In 2008, a modification to executive decree 16488-S increased the age of reporting of birth 
defects in the surveillance program to up to 1 year of age. This modification also provided 
for the inclusion of reporting from the National Children’s Hospital, a specialized pediatric 
treatment and referral center. All infants born with birth defects who are seen at this facility 
are crossed referenced with CREC’s database to ascertain any possible new or duplicated 
cases in the surveillance program. These changes to the surveillance program allowed for 
better ascertainment of birth defects. Since 2008, CREC has served as a national-based 
surveillance program that covers all 28 maternity hospitals in the country and the National 
Children’s Hospital.
History of Folic Acid Fortification in Costa Rica
In 1996, the third national nutrition survey in the country was undertaken, led by the 
Ministry of Health in collaboration with the National Reference Center of Bromatology 
(Centro Nacional de Referencia de Bromatología—CNRBro) at INCIENSA. This Center 
was given the responsibility of verifying and monitoring quality indicators and amounts of 
fortified staples. Similarly, the National Reference Center of Clinical-Chemistry (Centro 
Nacional de Referencia de Química Clínica—CNRQC) at INCIENSA was given the 
responsibility to collect and monitor blood folate concentrations nationally. This third 
national nutrition survey included measurements of serum folate concentrations from 
women of childbearing age (15–44 years). The mean serum folate concentration for women 
of childbearing age, conducted prior to fortification in the country, was reported as 10.1 
ng/mL (95 % CI 9.5–10.6) (Median 8.7 ng/mL) (radioimmunoassay-RIA) [16, 17]. Data 
from the 1996, third national nutrition survey indicated that approximately 25 % of women 
of child-bearing age in the country were possible or folate deficient (i.e., folate levels <6 
ng/mL) [16–18].
Since 1996, to address the concerns of nutritional deficiencies, several measures were taken 
to fortify basic staples of the Costa Rican diet with folic acid, iron, riboflavin, thiamine, and 
niacin. In October 1997, the 1st executive decree for the enrichment of wheat flour for 
human consumption with folic acid (1.5 mg/kg) and iron (55 mg/kg) was implemented for 
national, imported, and donated products [19]. In 1998, the 2nd executive decree mandated 
the establishment of a national commission on micronutrients [20]. In 1999, this commission 
developed the first comprehensive national plan and policy for the prevention of 
micronutrient deficiencies in the population [21]. One of the main objectives of the national 
plan was to prevent folate deficiency in women of childbearing age [21]. In September 
1999, a 3rd executive decree mandated fortification of corn flour with 1.3 mg/kg of folic 
acid, based on the premise that corn flour constituted a basic staple in the Costa Rican diet 
[22]. In 2001, the Ministry of Health in collaboration with one Costa Rican dairy company 
took the initiative to enrich whole, semi-skim, skim, and powdered milk with 40 μg folic 
acid/250 ml of milk. As a result, a 4th executive decree in 2001 mandated all dairy products 
to be fortified with folic acid [23]. In 2002, an amendment to the 1st executive decree for the 
enrichment of wheat flour increased the amount of folic acid in wheat flour from 1.5 to 1.8 
mg/kg [24]. In addition, in 2002 with the support of the rice industry, the Ministry of Health 
mandated rice to be fortified with folic acid (1.8 mg/kg) [25]. During the years 2008 and 
2009, following fortification, a national nutrition survey in the country was undertaken by 
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the Ministry of Health in collaboration with CNRBro and CNRQC at INCIENSA. This 
national nutrition survey showed that the mean serum folate concentration for women of 
childbearing age was 14.7 ng/mL (95 % CI 14.2–15.2) (Median 14.6 ng/mL) 
(chemiluminescence) [17, 26]. These data showed that although fortification was successful 
in raising folate concentrations, about 3.8 % of women of childbearing age in the country 
remained possible or folate deficient (i.e., folate levels <6 ng/mL) [17,18, 26].
CREC estimated the overall prevalence of neural tube defects (i.e., spina bifida, anencephaly 
and encephalocele) before and after fortification. Currently, few publications related to birth 
defects surveillance and fortification programs in Latin America are available in the 
literature. This paper could serve as an example to countries seeking to document prevention 
of birth defects and infant mortality by developing and strengthening their birth defects 
surveillance and fortification programs.
Methods
An analysis was conducted to estimate the overall prevalence of neural tube defects (i.e., 
spina bifida, anencephaly, and encephalocele) included in CREC from 1987–1991 to 1996–
2012. Data for the years 1992–1995 were excluded from the analysis, because not all 
hospitals in the country were participating during those years, as described previously. 
Prevalence was calculated based on the total number of infants born with neural tube defects 
included in CREC’s database from 1987–1991 to 1996–2012, divided by the total number of 
live births in the country from these same years, reported by the National Institute of 
Statistics and Census (Instituto Nacional de Estadistica y Censos—INEC). Although the 
mandate for fortification of wheat flour for human consumption with folic acid was 
published in the official Costa Rican newsletter in October 1997, the first infants impacted 
by fortification were likely not born until early 1999 when wheat fortification began to be 
fully implemented. Therefore, for purposes of this analysis, we considered the pre-
fortification time periods from 1987–1991 to 1996–1998, the years before any folic acid 
fortification mandate was implemented. The fortification implementation time period from 
1999 to 2002 included the years during which additional staples were fortified with folic 
acid. The post fortification time period from 2003 to 2012 included the years after all staples 
were fortified with folic acid (Table 1). A 95 % confidence interval (CI) was calculated for 
each prevalence estimate based on exact Poisson limits [27]. Statistical analyses were 
performed using SAS version 9.3 (SAS Institute, Cary, NC, USA). Geographical 
distribution of prevalence estimates by province (n = 7) in Costa Rica were performed using 
EPI INFO version 7 (Centers for Disease Control and Prevention, Atlanta, GA, USA). 
Provincial level maps were divided and grouped by different time periods: pre-fortification 
(1987–1991; 1996–1998), fortification implementation (1999–2002) and post-fortification 
(2003–2012) to show the overall prevalence of neural tube defects for these time periods. 
This analysis is based on public national birth defect surveillance data, for which no formal 
ethical review is required. All national surveillance data in Costa Rica are regulated by the 
executive decree 37306-S. No personal identifiers are associated with reported data.
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Prevalence of neural tube defects pre, during and post folic acid fortification in Costa Rica
A total of 1,170 infants born with neural tube defects were ascertained in the CREC’s 
database from 1987–1991 to 1996–2012; 628 infants born with neural tube defects from the 
pre-fortification time period (1987–1991; 1996–1998); 191 infants born with neural tube 
defects during the fortification implementation time period (1999–2002); and 351 infants 
from the post-fortification time period (2003–2012). Among the 1,170 infants born with 
neural tube defects, 88 infants had missing or no province name, and were excluded from 
the geographic analysis. There were 331 (28 %) infants born with anencephaly, 714 (61 %) 
infants born with spina bifida, and 125 (11 %) infants born with encephalocele obtained 
from CREC’s database from 1987–1991 to 1996–2012. Table 1 shows the prevalence of 
neural tube defects before, during, and after implementation of folic acid fortification of 
different staples in Costa Rica. The overall prevalence of neural tube defects decreased from 
9.8 per 10,000 live births (95 % CI 9.1–10.5) for the pre-fortification time period to 6.3 per 
10,000 live births (95 % CI 5.4–7.2) for the time period during fortification implementation, 
representing a statistically significant decrease of 35 %. Furthermore, the overall prevalence 
of neural tube defects decreased to 4.8 per 10,000 live births (95 % CI 4.3–5.3) for the post-
fortification time period, representing a statistically significant decrease of 51 % from the 
pre-fortification time period.
Figure 1 shows the yearly trends for the prevalence of neural tube defects registered in 
CREC’s database classified by time periods: pre-fortification, during fortification 
implementation, and post-fortification. A decrease in the overall prevalence of neural tube 
defects is observable throughout the span of 25 years. Figure 2 and Table 2 show the 
prevalence of neural tube defects in CREC’s database by province (n = 7). While the overall 
prevalence of neural tube defects by province declined throughout the years, there is still 
evidence of higher prevalence areas, specifically in the coastal areas and the areas on the 
border with neighboring countries (Fig. 2).
Discussion
The results of this analysis demonstrate that the birth prevalence of neural tube defects in 
Costa Rica has declined since the implementation of folic acid fortification in 1997. We 
observed a statistically significant decrease of 51 % in the prevalence of neural tube defects 
when comparing pre-fortification and post-fortification periods. This could be attributable to 
folic acid fortification through the availability of multiple food sources. Declining 
prevalence of neural tube defects was observed in most of the seven provinces. However, 
there are still areas with higher prevalence of neural tube defects that deserve special 
monitoring by CREC and assessment of fortification status. It would also be beneficial to 
ascertain blood folate status of women of childbearing age.
Costa Rica’s success in assessing the decrease of the prevalence of neural tube defects can 
be attributed to a series of events. Costa Rica has a Social Security System—a public and 
centralized system—that has been responsible for providing health care services to the 
population since 1948. This system has played an important role in the country’s 
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development and improvement of health outcome indicators, comparable to those in high 
income countries [28–30]. Improvements of basic health services throughout the years is 
considered to be one of the key elements that contributed to the general decline in infant 
mortality [28–30].
Moreover, the ongoing efforts led by the Ministry of Health and INCIENSA to increase the 
number of staples fortified with folic acid and to strengthen the surveillance of birth defects 
seem to have played an important role in contributing to the decline in the prevalence of 
neural tube defects and infant mortality due to neural tube defects [11,12]. Since the 
implementation of the folic acid fortification programs, Costa Rica has documented a 
decrease of neural tube defects birth prevalence, substantially diminishing the burden of 
neural tube defects mortality and morbidity [11,12]. Infant mortality related to neural tube 
defects before and after folic acid fortification was 0.64 per 1,000 live births (95 % CI 0.46–
0.82) and 0.17 per 1,000 live birth (95 % CI 0.08–0.28), respectively [11]. The surveillance 
data support the role of folic acid fortification in the decline of neural tube defects birth 
prevalence. In addition, the data also show 25 years of data of birth defect surveillance and 
illustrate differences in the prevalence of neural tube defects by time periods (pre, during 
and post folic acid fortification). The effectiveness of folic acid fortification of staple foods 
in the prevention of neural tube defects has been well-documented in the United States, 
Canada, and Chile [31–34]. Costa Rica is a unique example in the implementation of folic 
acid fortification programs, not only fortifying wheat flour as other high income countries 
have done [35], but also fortifying several basic food sources (e.g., corn flour, dairy products 
and rice) in order to reach as much of the population as possible. The formulation, 
negotiation, and approval of the first policy of wheat flour fortification with folic acid in 
Costa Rica in 1997, led by the Ministry of Health, was made possible by the combination of 
several favorable conditions in place at the time, including political will, industry 
compliance and the collaboration and contribution of many agencies [36]. It is likely that the 
understanding of the importance of folic acid fortification in the reduction of the prevalence 
of neural tube defects, coupled with the proactive collaboration of the Costa Rican milling 
and food industries played a vital role in institutionalizing and sustaining folic acid 
fortification programs.
A number of challenges exist for CREC’s surveillance system. Of particular importance is 
the need for a thorough evaluation of this passive surveillance system to ensure that the 
program’s objectives continue to be met and areas needing improvement are identified. As a 
passive system, CREC receives reports of birth defect cases from all hospitals without 
verification of cases. The program relies on local health care providers or health officers to 
report these data in a timely fashion. As a result, there could be variability in the 
completeness and accuracy of the data. To account for this, revision to the current 
surveillance protocol could include a process for data verification to identify completeness 
(i.e., possible missing cases), quality of case ascertainment (e.g., diagnosis validation 
through medical records review and validity audits), timeliness of reporting, and accuracy of 
the information reported. Reinforcement of training at participating hospitals could keep 
personnel motivated and assure the continuation of accurate, complete, and timely reporting. 
Finally, further studies are especially needed in remote areas of the country where higher 
prevalence of neural tube defects are reported (Fig. 2). Assessing reporting bias, potential 
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risk factors, and barriers to obtaining fortified staples are needed to understand the higher 
observed prevalence of neural tube defects in those areas. Addressing these issues will be 
critical to ensuring CREC’s continuity in monitoring birth defects, and sustainability of folic 
acid fortification programs in Costa Rica. Finally, although Costa Rica has reported 
increases in serum folate concentrations through their fortification efforts, different methods 
have been used to assess serum folate concentrations in different surveys. As a result, the 
findings must be interpreted with caution [17]. Therefore, implementation of standardized 
monitoring of red blood cell folate concentrations among women of childbearing age could 
be helpful in providing additional information on the impact of Costa Rica’s neural tube 
prevention initiatives.
Lessons Learned
There are many ways other countries can learn from and apply components of the Costa 
Rican experience in surveillance of birth defects and folic acid fortification measures for 
neural tube defects prevention. These include: (1) the implementation of an executive 
mandate to monitor the occurrence of birth defects by the leadership of CREC that has made 
birth defects surveillance structured and standardized; (2) strong and well-established 
partnerships with public and private maternity hospitals countrywide that have allowed 
officials at CREC to monitor the occurrence of birth defects over a period of 25 years; (3) 
the implementation of executive mandates to enrich several fortified staples (e.g., wheat, 
corn, dairy products, and rice) of the Costa Rican diet that has proven to be a successful 
public health intervention in reducing birth prevalence of neural tube defects in Costa Rica; 
(4) strong partnerships with industry that have been vital for the establishment and 
implementation of folic acid prevention programs; (5) the establishment of National 
Reference Center of Bromatology to control and monitor all fortified products to ensure 
compliance with all national and regional norms; and (6) the need to implement national 
nutrition surveys that include blood folate measurements among women of childbearing age, 
to monitor folic acid prevention measures.
Conclusion
Prior to the first initiative to fortify wheat flour with folic acid in 1997, Costa Rica had 
already been monitoring the occurrence of birth defects through passive surveillance for a 
decade and had assessed folate concentration among women of childbearing age in one 
population-based survey. These surveillance data would later allow for the comparison and 
monitoring of the prevalence of neural tube defects before, during the implementation of, 
and after the implementation of folic acid fortification of staple foods. This allowed health 
officials to demonstrate the importance of folic acid fortification for the prevention of neural 
tube defects. Although overall declines in prevalence have been seen, there remain segments 
of the population—primarily in remote areas—for which the prevalence of neural tube 
defects is higher than that of other geographic areas. Understanding the reasons for 
continued higher prevalence of neural tube defects in these remote areas (e.g., lack of folic 
acid supplementation, lack of access to fortified staples, genetic factors, etc.) remains an 
important mission for CREC and public health officials. Countries considering initiating 
birth defects surveillance and/or fortifying certain staples with folic acid will likely need to 
de la Paz Barboza-Argüello et al. Page 8













first assess existing infrastructure and build solid foundations and partnerships with different 
stakeholders (e.g., hospitals, industry, government officials, lawmakers, etc.). The example 
of a national surveillance system in Costa Rica demonstrates that achieving gains in the 
prevention of neural tube defects may take several years to accomplish.
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Prevalence trend for neural tube defects per 10,000 live-births in Costa Rica from 1987–
1991; 1996–2012. Source: Registry Center for Congenital Anomalies (Centro de Registro de 
Enfermedades Congénitas—CREC). Note: *1992–1995 data were excluded from the 
analysis because there were only 8 hospitals participating in CREC. Dotted lines denote data 
from 8 hospitals participating in CREC
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Prevalence of neural tube defects by province in Costa Rica 1987–1991; 1996–2012 (Pre, 
During and Post Folic Acid Fortification). Source: Registry Center for Congenital 
Anomalies (Centro de Registro de Enfermedades Congénitas—CREC). Note: *1992–1995 
data was excluded from the analysis because there were only 8 hospitals participating in 
CREC
de la Paz Barboza-Argüello et al. Page 12

























de la Paz Barboza-Argüello et al. Page 13
Table 1
Prevalence of neural tube defects, pre, during and post folic acid fortification
Years (period) Neural tube defects
prevalence (per 10,000 
live








Year published, type of fortified staples and


















0.65 35 % 1999: corn flour (1.3 mg/kg)
2001: dairy products (40 μg/250 ml)
2002: wheat flour (1.8 mg/kg)







0.49 51 % –
Source: Registry Center for Congenital Anomalies (Centro de Registro de Enfermedades Congénitas—CREC)
NA not applicable
*
1992–1995 data were excluded from the analysis because there were only 8 hospitals participating in CREC
†
Although published in October 1997, the first infants under this mandate were not likely born until early 1999
a
Values were significantly (p < 0.05) different from baseline (pre-fortification period; 1987–1991; 1996–1998)
b
Values were significantly (p < 0.05) different from baseline (pre-fortification period; 1987–1991; 1996–1998) and during fortification (1999–
2002)
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Table 2
Neural tube defects prevalence per 10,000 live births by province—Costa Rica, from 1987–1991; 1996–2012
Provinces San Jose
N
P (95 % CI)
Alajuela
N
P (95 % CI)
Cartago
N
P (95 % CI)
Heredia
N
P (95 % CI)
Guanacaste
N
P (95 % CI)
Puntarenas
N
P (95 % CI)
Limon
N
P (95 % CI)
1987–1991; 1996–1998
(pre-fortification)*

















































Source: Registry Center for Congenital Anomalies (Centro de Registro de Enfermedades Congénitas—CREC)
N number of cases
P prevalence per 10,000 live births
CI confidence interval
*
1992–1995 data were excluded from the analysis because there were only 8 hospitals participating in CREC
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